Raterman HG - Search Results

1

Critical issues and current challenges in osteoporosis and fracture prevention. An overview of unmet needs.

Lems WF, Raterman HG. Lems WF, et al. Among authors: raterman hg. Ther Adv Musculoskelet Dis. 2017 Dec;9(12):299-316. doi: 10.1177/1759720X17732562. Epub 2017 Oct 27. Ther Adv Musculoskelet Dis. 2017. PMID: 29201155 Free PMC article. Review.

2

The metabolic syndrome is amplified in hypothyroid rheumatoid arthritis patients: a cross-sectional study.

Raterman HG, van Eijk IC, Voskuyl AE, Peters MJ, Dijkmans BA, van Halm VP, Simsek S, Lems WF, Nurmohamed MT. Raterman HG, et al. Ann Rheum Dis. 2010 Jan;69(1):39-42. doi: 10.1136/ard.2008.100776. Ann Rheum Dis. 2010. PMID: 19103637

3

Rituximab and thyroid function.

Raterman HG, Simsek S, Lems WF, Meesters EW, Dijkmans BA, Nurmohamed MT. Raterman HG, et al. Arch Intern Med. 2009 Jun 8;169(11):1073-4. doi: 10.1001/archinternmed.2009.116. Arch Intern Med. 2009. PMID: 19506179 No abstract available.

4

Work ability: a new outcome measure in rheumatoid arthritis?

Raterman HG, Hoving JL, Nurmohamed MT, Herenius MM, Sluiter JK, Lems WF, Tak PP, Dijkmans BA, Twisk J, Frings-Dresen MH, Voskuyl AE. Raterman HG, et al. Scand J Rheumatol. 2010 Mar;39(2):127-31. doi: 10.3109/03009740903447044. Scand J Rheumatol. 2010. PMID: 20059369

5

Improvement of work ability, quality of life, and fatigue in patients with rheumatoid arthritis treated with adalimumab.

Herenius MM, Hoving JL, Sluiter JK, Raterman HG, Lems WF, Dijkmans BA, Tak PP, Nurmohamed MT, Voskuyl AE, Frings-Dresen MH. Herenius MM, et al. Among authors: raterman hg. J Occup Environ Med. 2010 Jun;52(6):618-21. doi: 10.1097/JOM.0b013e3181de8357. J Occup Environ Med. 2010. PMID: 20523240

6

Improvement of thyroid function in hypothyroid patients with rheumatoid arthritis after 6 months of adalimumab treatment: a pilot study.

Raterman HG, Jamnitski A, Lems WF, Voskuyl AE, Dijkmans BA, Bos WH, Simsek S, Lips P, van de Stadt RJ, de Koning MH, Nurmohamed MT. Raterman HG, et al. J Rheumatol. 2011 Feb;38(2):247-51. doi: 10.3899/jrheum.100488. Epub 2010 Nov 15. J Rheumatol. 2011. PMID: 21078720

7

(Sub)clinical cardiovascular disease is associated with increased bone loss and fracture risk; a systematic review of the association between cardiovascular disease and osteoporosis.

den Uyl D, Nurmohamed MT, van Tuyl LH, Raterman HG, Lems WF. den Uyl D, et al. Among authors: raterman hg. Arthritis Res Ther. 2011 Jan 17;13(1):R5. doi: 10.1186/ar3224. Arthritis Res Ther. 2011. PMID: 21241491 Free PMC article. Review.

8

Pharmacological induction of interferon type I activity following treatment with rituximab determines clinical response in rheumatoid arthritis.

Vosslamber S, Raterman HG, van der Pouw Kraan TC, Schreurs MW, von Blomberg BM, Nurmohamed MT, Lems WF, Dijkmans BA, Voskuyl AE, Verweij CL. Vosslamber S, et al. Among authors: raterman hg. Ann Rheum Dis. 2011 Jun;70(6):1153-9. doi: 10.1136/ard.2010.147199. Epub 2011 Mar 27. Ann Rheum Dis. 2011. PMID: 21444302 Clinical Trial.

9

Osteopenia: a diagnostic and therapeutic challenge.

Lems WF, Raterman HG, van den Bergh JP, Bijlsma HW, Valk NK, Zillikens MC, Geusens P. Lems WF, et al. Among authors: raterman hg. Curr Osteoporos Rep. 2011 Sep;9(3):167-72. doi: 10.1007/s11914-011-0062-3. Curr Osteoporos Rep. 2011. PMID: 21695407 Free PMC article.

10

The interferon type I signature towards prediction of non-response to rituximab in rheumatoid arthritis patients.

Raterman HG, Vosslamber S, de Ridder S, Nurmohamed MT, Lems WF, Boers M, van de Wiel M, Dijkmans BA, Verweij CL, Voskuyl AE. Raterman HG, et al. Arthritis Res Ther. 2012 Apr 27;14(2):R95. doi: 10.1186/ar3819. Arthritis Res Ther. 2012. PMID: 22540992 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

43 results

Search Page